Specific suppression of interleukin-2 biosynthesis by synthetic antisense oligodeoxynucleotides does not influence allograft rejection

Transplant Proc. 2001 Feb-Mar;33(1-2):306. doi: 10.1016/s0041-1345(00)02019-4.

Authors

S Yun¹, G Sawyer, X Zhang, K Gustafsson, J W Fabre

Affiliation

¹ Department of Clinical Sciences, Institute of Liver Studies, Guy's, King's and St Thomas' School of Medicine, King's College Hospital, London, UK.

PMID: 11266830
DOI: 10.1016/s0041-1345(00)02019-4

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Graft Rejection / immunology*
Graft Rejection / prevention & control
Interleukin-2 / biosynthesis*
Interleukin-2 / pharmacology
Kidney Transplantation / immunology*
Lymphocyte Activation / drug effects
Oligodeoxyribonucleotides, Antisense / pharmacology*
Rats
Transplantation Tolerance / immunology*

Substances

Interleukin-2
Oligodeoxyribonucleotides, Antisense